DSM-Firmenich AG
AEX:DSFIR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
DSM-Firmenich AG
Change in Working Capital
DSM-Firmenich AG
Change in Working Capital Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Change in Working Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
D
|
DSM-Firmenich AG
AEX:DSFIR
|
Change in Working Capital
-€530m
|
CAGR 3-Years
5%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Sika AG
F:SIKA
|
Change in Working Capital
-CHf200.2m
|
CAGR 3-Years
32%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
0%
|
|
|
C
|
Clariant AG
SIX:CLN
|
Change in Working Capital
-CHf121m
|
CAGR 3-Years
18%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
Givaudan SA
SIX:GIVN
|
Change in Working Capital
-CHf275m
|
CAGR 3-Years
19%
|
CAGR 5-Years
3%
|
CAGR 10-Years
-3%
|
|
|
Ems Chemie Holding AG
SIX:EMSN
|
Change in Working Capital
-CHf80.2m
|
CAGR 3-Years
35%
|
CAGR 5-Years
4%
|
CAGR 10-Years
3%
|
|
|
Dottikon Es Holding AG
SIX:DESN
|
Change in Working Capital
-CHf11.3m
|
CAGR 3-Years
28%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
7%
|
|
DSM-Firmenich AG
Glance View
DSM-Firmenich AG is the culmination of a merger between two titans in their respective fields: DSM, a Dutch multinational known for its prowess in health, nutrition, and sustainable living, and Firmenich, a Swiss firm renowned for its legacy in fragrances and flavors. This strategic union blends DSM's strengths in innovative biotechnology and sustainability with Firmenich's expertise in creating unique sensory experiences. As a combined entity, DSM-Firmenich AG operates on the cutting edge of scientific innovation, catering to a diverse array of industries including food and beverages, personal care, and health products. The synergy of DSM's leadership in sustainable solutions with Firmenich's artistry in scent and flavor not only results in high-quality consumer products but also pushes the envelope in terms of environmental responsibility and human health. The company's business model thrives on innovation and a deep understanding of consumer needs. It leverages its extensive research and development capabilities to produce solutions that enhance the taste, texture, and nutritional value of food, alongside creating signature scents for personal and home care products. By consistently investing in technology and sustainable practices, DSM-Firmenich generates revenue through a broad portfolio of offerings that cater to global clients ranging from multinational corporations to niche brands. Their growth is anchored in delivering products that resonate with consumers' increasing demands for sustainability and authenticity, ensuring that every product not only meets the highest standards of quality but also aligns with the values of a rapidly changing world.
See Also
What is DSM-Firmenich AG's Change in Working Capital?
Change in Working Capital
-530m
EUR
Based on the financial report for Dec 31, 2025, DSM-Firmenich AG's Change in Working Capital amounts to -530m EUR.
What is DSM-Firmenich AG's Change in Working Capital growth rate?
Change in Working Capital CAGR 3Y
5%
Over the last year, the Change in Working Capital growth was -588%. The average annual Change in Working Capital growth rates for DSM-Firmenich AG have been 5% over the past three years .